These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24763730)

  • 1. Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.
    Hall EH; Liu Y; Xiao A; Shock L; Brautigan DL; Mayo MW; Adusumilli PS; Jones DR
    PLoS One; 2014; 9(4):e95869. PubMed ID: 24763730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
    Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
    Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPAN2 is involved in cell invasion and motility during lung cancer progression.
    Otsubo C; Otomo R; Miyazaki M; Matsushima-Hibiya Y; Kohno T; Iwakawa R; Takeshita F; Okayama H; Ichikawa H; Saya H; Kiyono T; Ochiya T; Tashiro F; Nakagama H; Yokota J; Enari M
    Cell Rep; 2014 Apr; 7(2):527-538. PubMed ID: 24726368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
    Smith PW; Liu Y; Siefert SA; Moskaluk CA; Petroni GR; Jones DR
    Cancer Lett; 2009 Apr; 276(2):196-203. PubMed ID: 19111386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma.
    Babu D; Chintal R; Panigrahi M; Phanithi PB
    Cell Oncol (Dordr); 2022 Dec; 45(6):1451-1465. PubMed ID: 36284039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.
    Sato M; Larsen JE; Lee W; Sun H; Shames DS; Dalvi MP; Ramirez RD; Tang H; DiMaio JM; Gao B; Xie Y; Wistuba II; Gazdar AF; Shay JW; Minna JD
    Mol Cancer Res; 2013 Jun; 11(6):638-50. PubMed ID: 23449933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
    Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
    Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.
    Boudreau HE; Casterline BW; Burke DJ; Leto TL
    Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.
    Ines C; Donia O; Rahma B; Ben Ammar A; Sameh A; Khalfallah T; Abdelmajid BH; Sabeh M; Saadia B
    Tumour Biol; 2014 Jul; 35(7):7163-75. PubMed ID: 24763823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
    Cho KH; Yu SL; Cho DY; Park CG; Lee HY
    BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
    Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
    Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
    Sheng XJ; Zhou YQ; Song QY; Zhou DM; Liu QC
    Oncol Rep; 2012 Apr; 27(4):1011-8. PubMed ID: 22200669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
    Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
    Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.